Comparative review of novel model-assisted designs for phase I clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative review of novel model-assisted designs for phase I clinical trials

Published:2018-04-22 Issue:14 Volume:37 Page:2208-2222
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Zhou Heng¹^ORCID,Murray Thomas A.²^ORCID,Pan Haitao³^ORCID,Yuan Ying¹^ORCID

Affiliation:

1. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Biostatistics; The University of Minnesota; Minneapolis MN USA

3. Department of Biostatistics; St. Jude Children's Research Hospital; Memphis TN USA

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference31 articles.

1. Dose escalation methods in phase I cancer clinical trials;Le Tourneau;J Nat Cancer Inst,2009

2. Shortening the timeline of pediatric phase I trials: the rolling six design;Skolnik;J Clin Oncol,2008

3. A random walk rule for phase I clinical trials;Durham;Biometrics,1997

4. Improved up-and-down designs for phase I trials;Ivanova;Stat Med,2003

5. The accelerated biased coin up-and-down design in phase I trials;Stylianou;J Biopharm Stat,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should the choice of BOIN design parameterp.toxonly depend on the target DLT rate?;2024-03-07

2. First‐in‐human study of CPL207280, a novel G‐protein‐coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration;Diabetes, Obesity and Metabolism;2024-01-11

3. Two-dimensional calibration-free odds design for phase I drug-combination trials;Frontiers in Oncology;2023-11-29

4. Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity;Frontiers in Pharmacology;2023-11-22

5. Enhancement of Bayesian optimal interval design by accounting for overdose and underdose errors trade-offs;Journal of Biopharmaceutical Statistics;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3